NEW YORK, Nov. 11, 2026 /PRNewswire/ -- 5W, one of the largest independently owned public relations firms in the U.S., today announced it has been named Agency of Record for nuBioAge, a physician-focused longevity medicine company helping healthcare professionals translate scientific advancements into practical, personalized patient care.
Founded by pharmacists Leonard Pastrana and Franck Kacou, nuBioAge brings together clinical experts, educational resources, and industry partners to help medical professionals incorporate longevity medicine into their practices. Through its professional education programs, multidisciplinary scientific team, and network of companies offering advanced diagnostics, technologies, and clinical solutions, nuBioAge gives practitioners access to the knowledge and resources needed to navigate an evolving field.
"Longevity medicine is an exciting and rapidly growing space, and there's so much opportunity to bring these conversations to a broader audience," said Ashley Barton, EVP, Consumer Lifestyle & Multicultural, 5W. "What nuBioAge is doing to connect emerging science with real-world clinical practice is important, and we're excited to help tell that story, elevate its leadership, and bring more visibility to the people and innovations shaping the future of healthcare."
As Agency of Record, 5W will lead a strategic communications program encompassing national media relations, executive thought leadership, and targeted product seeding to strengthen nuBioAge's positioning in clinical longevity medicine. The agency will also position co-founders Leonard Pastrana, PharmD, and Franck Kacou, PharmD, MBA, as expert voices on physician education, emerging therapies, and the future of personalized healthcare through media interviews, profiles, and expert commentary.
5W will also support publicity for CALM 2027 (Clinical Application of Longevity Medicine), taking place February 19–20 in Fort Lauderdale, Florida. The annual conference brings together leading physicians, scientists, and industry experts to explore the practical application of longevity medicine, with programming spanning peptide therapies, advanced diagnostics, artificial intelligence, and strategies for building successful medical practices. Through national media outreach, 5W will help raise awareness of the event and its role in advancing clinical education and collaboration.
"The future of longevity medicine isn't just about discovering new therapies or following emerging trends. It's about building the clinical, regulatory, and operational infrastructure needed to expand patient access and bring innovation into everyday medical practice safely and responsibly," said Franck Kacou, PharmD, MBA, Co-Founder of nuBioAge. "Our partnership with 5W will help amplify that mission, connect with more healthcare professionals, and bring greater visibility to the physicians and innovators shaping the future of longevity medicine."
For more information about nuBioAge, visit nubioage.com.
For more information about 5W, visit 5wpr.com.
About 5W
5W is an independent PR, creative and AI Visibility agency headquartered in Miami, Florida, with offices in New York, Miami and Tampa. We get clients into the chatbox, the AI answers that increasingly shape what customers buy. Founded in 2003, 5W works with Fortune 500, Fortune 1000 and Inc. 500 companies and has itself been named to the Inc. 500. The agency does all of its work in house, including media relations, creative, video production, social media and content, supported by proprietary technology. Learn more at www.5wpr.com.
About nuBioAge
nuBioAge is a physician-focused clinical longevity medicine ecosystem built to help medical practices deliver personalized longevity care. At the center of the organization is a multidisciplinary scientific team bringing together a broad range of clinical expertise. Through this breadth of practicing clinical expertise, nuBioAge develops education and professional learning platforms that help healthcare providers evaluate emerging therapies, advanced diagnostics, and evidence-informed approaches to patient care. Beyond education, nuBioAge identifies and connects physicians with companies offering the technologies, diagnostics, formulations, and services needed to put longevity medicine into practice. By bringing together clinicians, education, industry partners, and a growing professional community, nuBioAge builds the infrastructure that supports physicians in delivering clinical longevity medicine.
About CALM
CALM (Clinical Application of Longevity Medicine) is a physician-focused conference dedicated to the real-world practice of longevity medicine. It brings together experienced, actively practicing clinicians who teach how they apply emerging therapies, advanced diagnostics, and personalized treatment strategies in patient care, sharing clinical insights and practical experience with their peers. Designed as a gathering place for the clinical longevity medicine community, CALM gives physicians an opportunity to learn from one another, collaborate across specialties, and build lasting professional relationships. Unlike consumer wellness or biohacking events, CALM is centered on medical practice, with a curated group of participating companies selected for their relevance to physicians delivering longevity care, including providers of diagnostics, technologies, therapeutics, and clinical solutions. CALM is where the clinicians and companies advancing longevity medicine come together to shape how it is practiced.
SOURCE 5W Public Relations
Share this article